Quest Diagnostics Incorporated

NYSE DGX

Quest Diagnostics Incorporated Receivables for the quarter ending December 31, 2024: USD 1.30 B

Quest Diagnostics Incorporated Receivables is USD 1.30 B for the quarter ending December 31, 2024, a 7.77% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.
  • Quest Diagnostics Incorporated Receivables for the quarter ending December 31, 2023 was USD 1.21 B, a 1.26% change year over year.
  • Quest Diagnostics Incorporated Receivables for the quarter ending December 31, 2022 was USD 1.20 B, a -16.90% change year over year.
  • Quest Diagnostics Incorporated Receivables for the quarter ending December 31, 2021 was USD 1.44 B, a -5.39% change year over year.
  • Quest Diagnostics Incorporated Receivables for the quarter ending December 31, 2020 was USD 1.52 B, a 42.99% change year over year.
Key data
Date Receivables Inventory Goodwill Total Assets
Market news
Loading...
SV Wall Street
NYSE: DGX

Quest Diagnostics Incorporated

Description

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Similar companies

IDXX

IDEXX Laboratories, Inc.

USD 469.04

11.13%

ICLR

ICON Public Limited Company

USD 199.08

-1.31%

SHC

Sotera Health Company

USD 13.71

0.00%

RVTY

Revvity, Inc.

USD 123.69

-1.93%

IQV

IQVIA Holdings Inc.

USD 199.11

-1.12%

A

Agilent Technologies, Inc.

USD 148.63

-1.91%

CRL

Charles River Laboratories International, Inc.

USD 161.62

-1.91%

WAT

Waters Corporation

USD 411.19

-1.03%

TWST

Twist Bioscience Corporation

USD 52.75

0.73%

MTD

Mettler-Toledo International Inc.

USD 1.34 K

-1.61%

StockViz Staff

February 4, 2025

Any question? Send us an email